Author

Zhenmiao Wan

h-index 4 View on Semantic Scholar

We have 2 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

SLC11A1 upregulation mediates the progression of hepatocellular carcinoma and decreased sensitivity to cisplatin by mediating macrophage M2 polarization.

BACKGROUND Dysregulated expression of Solute Carrier Family 11 Member 1 (SLC11A1) has been found to be dysregulated in multiple human cancers and is implicated in tumor progression. However, the precise functions and underlying mechanisms of SLC11A1 in hepatocellular carcinoma (HCC) remains largely unknown. METHODS T...

Rui-Yao Zhou, Li-Min Ruan, Chao-Hui Wu et al. · Pathology, Research and Prac... · 0 citations

Open access Jul 2026

High Expression of SAMM50 Indicates Poor Clinical Prognosis in Hepatocellular Carcinoma and Represents a Potential Novel Biomarker.

This research demonstrated that the mRNA and protein levels of SAMM50 in HCC tissues were elevated compared to those in normal liver and adjacent tissues, suggesting its potential as a diagnostic marker for HCC, though further validation in independent cohorts is needed.

Huawei Zhai, Bang-Lian Cai, Zihao Zheng et al. · Biological Procedures Online · 0 citations